Supramolecular medicinal chemistry: Mixed-ligand coordination complexes

被引:56
作者
Ma, Zhenbo [1 ]
Moulton, Brian [1 ]
机构
[1] Brown Univ, Dept Chem, Providence, RI 02912 USA
关键词
solubility; lipophilicity; metal-drug; mixed ligand; QSAR; NSAID; partition coefficient; solubility ratio; pharmaceutical cocrystal; complementary; noncovalent;
D O I
10.1021/mp070013k
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We report on the supramolecular synthesis and characterization of examples from three series of mixed-ligand coordination complexes composed of copper(II), a drug, and an ancillary ligand (AL). Particularly, we demonstrate how the judicious choice of an ancillary ligand affords a large degree of control over the relative lipophilicity/hydrophilicity of the complex in relation to the uncomplexed drug molecule. Furthermore, we demonstrate several important factors to consider in the design of such complexes such as the additive-constitutive nature of the partition coefficient of the ancillary ligand and the relative size of the two types of ligands.
引用
收藏
页码:373 / 385
页数:13
相关论文
共 51 条
[1]   Benzimidazol-1-yl)methyl]benzamides as bifunctional reagents for reliable inorganic-organic supramolecular synthesis [J].
Aakeroy, CB ;
Desper, J ;
Smith, MM ;
Urbina, JF .
DALTON TRANSACTIONS, 2005, (14) :2462-2470
[2]   SYNTHESIS, CHARACTERIZATION AND CATECHOLASE-MIMETIC ACTIVITY OF MONONUCLEAR COPPER(II) ASPIRINATE COMPLEXES [J].
ABUHIJLEH, AL ;
WOODS, C ;
BOGAS, E ;
LEGUENNIOU, G .
INORGANICA CHIMICA ACTA, 1992, 195 (01) :67-71
[3]   MONONUCLEAR AND BINUCLEAR COPPER(II) COMPLEXES OF THE ANTIINFLAMMATORY DRUG IBUPROFEN - SYNTHESIS, CHARACTERIZATION, AND CATECHOLASE-MIMETIC ACTIVITY [J].
ABUHIJLEH, AL .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1994, 55 (04) :255-262
[4]   Discrimination of metallosupramolecular architectures in solution by using diffusion ordered spectroscopy (DOSY) experiments: Double-stranded helicates of different lengths [J].
Allouche, Lionel ;
Marquis, Annie ;
Lehnl, Jean-Marie .
CHEMISTRY-A EUROPEAN JOURNAL, 2006, 12 (28) :7520-7525
[5]   Crystal engineering of the composition of pharmaceutical phases.: Do pharmaceutical co-crystals represent a new path to improved medicines? [J].
Almarsson, Ö ;
Zaworotko, MJ .
CHEMICAL COMMUNICATIONS, 2004, (17) :1889-1896
[6]  
[Anonymous], 1989, TRANSITION METAL COM
[7]   EFFECT OF PRECURSOR CORE STRUCTURE ON THE HYDROGENATION OF 1,3-BUTADIENE CATALYZED BY CLUSTER-DERIVED MODEL CATALYSTS [J].
BANARES, MA ;
DAUPHIN, L ;
LEI, XJ ;
CEN, W ;
SHANG, MY ;
WOLF, EE ;
FEHLNER, TP .
CHEMISTRY OF MATERIALS, 1995, 7 (03) :553-561
[8]   Copper [J].
Barceloux, DG .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1999, 37 (02) :217-230
[9]   SUPEROXIDE-DISMUTASE ACTIVITY OF CU(II)2(ASPIRINATE)4 AND ITS ADDUCTS WITH NITROGEN AND OXYGEN DONORS [J].
BHIRUD, RG ;
SRIVASTAVA, TS .
INORGANICA CHIMICA ACTA, 1990, 173 (01) :121-125
[10]  
Cameron Beth R., 2001, Journal of Inorganic Biochemistry, V83, P233, DOI 10.1016/S0162-0134(00)00184-7